Old Web
English
Sign In
Acemap
>
authorDetail
>
Oliver James Philps
Oliver James Philps
The Hertz Corporation
Chemistry
Kinase
LRRK2
Biochemistry
Kinome
4
Papers
12
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
5-Substituted-N-pyridazinylbenzamides as potent and selective LRRK2 inhibitors: Improved brain unbound fraction enables efficacy
2019
Bioorganic & Medicinal Chemistry Letters
Xiao Ding
Luigi Piero Stasi
Xuedong Dai
Kai Long
Cheng Peng
Baowei Zhao
Hailong Wang
Changhui Sun
Huan Hu
Zehong Wan
Karamjit Singh Jandu
Oliver James Philps
Yan Chen
Lizhen Wang
Qian Liu
Colin Edge
Yi Li
Kelly Dong
Xiaoming Guan
F. David Tattersall
Alastair D. Reith
Feng Ren
Show All
Source
Cite
Save
Citations (3)
Discovery of 5-substituent-N-arylbenzamide derivatives as potent, selective and orally bioavailable LRRK2 inhibitors
2017
Bioorganic & Medicinal Chemistry Letters
Xiao Ding
Xuedong Dai
Kai Long
Cheng Peng
Daniele Andreotti
Paul Bamborough
Andrew John Eatherton
Colin Edge
Karamjit Singh Jandu
Paula Louise Nichols
Oliver James Philps
Luigi Piero Stasi
Zehong Wan
Jia-Ning Xiang
Kelly Dong
Pamela Dossang
Ming-Hsun Ho
Yi Li
Lucy M. Mensah
Xiaoming Guan
Alastair D. Reith
Feng Ren
Show All
Source
Cite
Save
Citations (9)
2- (Benzyloxy) benzamides as kinase inhibitors LRRK2
2011
Daniele Andreotti
Xuedong Dai
Andrew John Eatherton
Karamjit Singh Jandu
Qian Liu
Oliver James Philps
Show All
Source
Cite
Save
Citations (0)
2-(benzyloxy) benzamides en tant qu'inhibiteurs de la lrrk2 kinase
2011
Daniele Andreotti
Xuedong Dai
Andrew John Eatherton
Karamjit Singh Jandu
Qian Liu
Oliver James Philps
Show All
Source
Cite
Save
Citations (0)
1